Within the product type segmentation, Monoclonal Antibodies (mAbs) stand out as the definitive market leader, not only dominating the biopharmaceutical segment but also holding the largest share of the overall biologics R&D pipeline. Monoclonal antibodies are precision-engineered proteins designed to specifically bind to target antigens (like cancer cell receptors or inflammatory...